Literature DB >> 6456893

Cefoperazone in Klebsiella meningitis: a case report.

R B Ellis-Pegler, S D Lang.   

Abstract

A 51-year-old man with meningitis due to Klebsiella pneumoniae was treated with cefoperazone 6 to 8 g/day intravenously and was cured. Simultaneous blood and cerebrospinal fluid levels were measured. Trough levels of cefoperazone in cerebrospinal fluid were 9 and 12 mg/L. Cefoperazone should be considered for meningitis due to susceptible organisms resistant to customarily used antibacterial drugs.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6456893     DOI： 10.2165/00003495-198100221-00015

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  7 in total

Review 1.  Drug therapy: The newer cephalosporins.

Authors:  R C Moellering; M N Swartz
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

2.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

3.  Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.

Authors:  L B Reller; C W Stratton
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

4.  Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; C C Cherubin; M Gombert; D Cleri
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

5.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

6.  Intravenous cefotaxime in children with bacterial meningitis.

Authors:  B H Belohradsky; K Bruch; D Geiss; D Kafetzis; W Marget; G Peters
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

7.  Meningitis caused by gram-negative bacilli.

Authors:  S L Berk; W R McCabe
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391
  7 in total
  4 in total

Review 1.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

Review 2.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

3.  Pharmacokinetic evaluation of cefoperazone in infants.

Authors:  M Varghese; A J Khan; K Kumar; W Rosenfeld; H A Schaeffer; H E Evans
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 4.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.